MARKET

LVTX

LVTX

Lava Therapeutics Bv
NASDAQ
1.300
-0.030
-2.26%
After Hours: 1.360 +0.06 +4.62% 16:01 03/14 EDT
OPEN
1.350
PREV CLOSE
1.330
HIGH
1.350
LOW
1.292
VOLUME
17.80K
TURNOVER
--
52 WEEK HIGH
4.210
52 WEEK LOW
0.8502
MARKET CAP
34.19M
P/E (TTM)
-1.2751
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LVTX last week (0303-0307)?
Weekly Report · 6d ago
Weekly Report: what happened at LVTX last week (0224-0228)?
Weekly Report · 03/03 09:24
LAVA THERAPEUTICS NV - RECEIVES NASDAQ NON-COMPLIANCE NOTICE FOR MINIMUM BID PRICE
Reuters · 02/28 21:11
Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang
Benzinga · 02/28 17:32
This Constellation Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Benzinga · 02/27 17:58
Lava Therapeutics Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones · 02/27 14:02
HC Wainwright & Co. Downgrades LAVA Therapeutics to Neutral, Lowers Price Target to $1.5
Benzinga · 02/27 13:53
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
TipRanks · 02/27 11:41
More
About LVTX
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

Webull offers LAVA Therapeutics NV stock information, including NASDAQ: LVTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LVTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LVTX stock methods without spending real money on the virtual paper trading platform.